Where does Ensoma's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Ensoma's 3 recorded funding rounds.

Premier Alternatives

Ensoma

Drug Discovery · Boston, MA · Founded 2019 · Privately Held (backing)

Operator of a biotech company intended to develop a genomic medicine in vivo approach to engineer any or all blood and immune cells to cure diseases. Ensoma is based in Boston, MA and was founded in 2019. Its last reported valuation was $280 million in May 2023. It has raised $258 million across 3 recorded rounds; the latest was a $53 million Series B1 in Sep 2025.

Last reported valuation

$280.0M

Oct 2026

Priced at

—

Total raised

$258.0M

Last round

Later Stage VC (Series B1)

Sep 2025

Cap table — not yet on record

Ensoma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Ensoma with a free account

·The complete investor list: 21 names
·Watch Ensoma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Ensoma

Where does Ensoma's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Ensoma's 3 recorded funding rounds.